BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11497301)

  • 1. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation.
    Raaphorst GP; Cybulski SE; Sobol R; Ng CE
    Anticancer Res; 2001; 21(3B):2079-83. PubMed ID: 11497301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C; Singh G; Lukka H; Rainbow AJ
    Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Ng CE
    Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human tumour cell responses to cisplatin and ZD0473 with and without irradiation.
    Raaphorst GP; Yang DP; Li LF; Malone S
    Anticancer Res; 2004; 24(2B):613-8. PubMed ID: 15161002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.
    Raaphorst GP; Wilkins DE; Mao JP; Miao JC; Ng CE
    Radiat Oncol Investig; 1999; 7(3):153-7. PubMed ID: 10406056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
    Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
    Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to pulsed dose rate and low dose rate irradiation with and without mild hyperthermia using human breast carcinoma cell lines.
    Niedbala M; McNamee JP; Raaphorst GP
    Int J Hyperthermia; 2006 Feb; 22(1):61-75. PubMed ID: 16423753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation response of drug-resistant variants of a human breast cancer cell line.
    Lehnert S; Greene D; Batist G
    Radiat Res; 1989 Jun; 118(3):568-80. PubMed ID: 2727277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is DNA polymerase beta important in thermal radiosensitization?
    Raaphorst GP; Yang DP; Niedbala G
    Int J Hyperthermia; 2004 Mar; 20(2):140-3. PubMed ID: 15195508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
    Nagy B; Mucsi I; Molnár J; Thurzo L
    Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O; Powell TM; Marples B; Joiner MC; Scott SD
    Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents.
    Bergoglio V; Canitrot Y; Hogarth L; Minto L; Howell SB; Cazaux C; Hoffmann JS
    Oncogene; 2001 Sep; 20(43):6181-7. PubMed ID: 11593426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.
    Geldof AA; Kruit A; Newling DW; Slotman BJ
    Anticancer Res; 1999; 19(1A):505-8. PubMed ID: 10226589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of potentially lethal damage recovery by cisplatin in a brain tumor cell line.
    Wilkins DE; Heller DP; Raaphorst GP
    Anticancer Res; 1993; 13(6A):2137-42. PubMed ID: 8297126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of radiosensitivity in Chinese hamster lung fibroblasts by cisplatin.
    Akudugu JM; Slabbert JP
    Can J Physiol Pharmacol; 2008 May; 86(5):257-63. PubMed ID: 18432286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cisplatin response in three radiation resistant and three radiation sensitive cell lines.
    Raaphorst GP; Wang G; Wilkins D; Davis L; Bussey A; Stewart D; Ng CE
    Anticancer Res; 1994; 14(5A):1939-42. PubMed ID: 7847831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
    Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
    Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1.
    Yde CW; Issinger OG
    Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
    Blaese MA; Santo-Hoeltje L; Rodemann HP
    Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.